CTRI/2021/09/036354尚未招募2 期
PHASE II NON RANDOMIZED CLINICAL STUDY ON SURAPEENISAM (SINUSITIS ) WITH THE EVALUATION OF THE SIDDHA TRIAL DRUG AMIRTHATHI NEI(INTERNAL) ELUMICHANKAI ENNAI(EXTERNAL) IN CHILDRE
Government Siddha Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Nasal congestion
- •Recurrent sneezing
- •Running nose
- •Pain and tenderness over PNS
排除标准
- •Vasomotor rhinitis
- •Ophthalmic headache
- •Otitis media
研究者
相似试验
尚未招募
2 期
Peenisathirku chooranam(internal)for Surapeenisam(Sinusitis in children)CTRI/2024/07/070139Goverment siddha medical college
尚未招募
2 期
Adakki kashayam for sura peenisam(sinusitis) in childreCTRI/2022/11/047576Government siddha medical college
进行中（未招募）
1 期
A study to evaluate the switch from prednisone to dexamethasone in prostate cancer patients being treated with abirateroneEUCTR2021-000943-30-ESSOGUG (Spanish Genitourinary Oncologic Group)110
进行中（未招募）
1 期
A study before surgery evaluating Regimens with Weekly Paclitaxel plus Neratinib or Trastuzumab or Neratinib and Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab in Women with Locally Advanced HER2-Positive Breast Cancer.ocally advanced HER2-positive breast cancerMedDRA version: 16.1Level: PTClassification code 10065430Term: HER-2 positive breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: LLTClassification code 10072740Term: Locally advanced breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004391-35-ESPuma Biotechnology Inc.126
进行中（未招募）
1 期
A study before surgery evaluating Regimens with Weekly Paclitaxel plus Neratinib or Trastuzumab or Neratinib and Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab in Women with Locally Advanced HER2-Positive Breast Cancer.ocally advanced HER2-positive breast cancerMedDRA version: 16.1Level: PTClassification code 10065430Term: HER-2 positive breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: LLTClassification code 10072740Term: Locally advanced breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004391-35-PTPuma Biotechnology Inc.126